- Home
- HCWB vs LUCY Comparison
HCWB vs LUCY Comparison
Compare HCWB & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- LUCY
- Stock Information
- Founded
- HCWB 2018
- LUCY 2017
- Country
- HCWB United States
- LUCY United States
- Employees
- HCWB N/A
- LUCY N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- LUCY Ophthalmic Goods
- Sector
- HCWB Health Care
- LUCY Health Care
- Exchange
- HCWB Nasdaq
- LUCY Nasdaq
- Market Cap
- HCWB 17.2M
- LUCY 14.5M
- IPO Year
- HCWB 2021
- LUCY 2022
- Fundamental
- Price
- HCWB $0.39
- LUCY $4.55
- Analyst Decision
- HCWB
- LUCY Strong Buy
- Analyst Count
- HCWB 0
- LUCY 1
- Target Price
- HCWB N/A
- LUCY $20.00
- AVG Volume (30 Days)
- HCWB 18.3M
- LUCY 22.7K
- Earning Date
- HCWB 03-31-2025
- LUCY 03-24-2025
- Dividend Yield
- HCWB N/A
- LUCY N/A
- EPS Growth
- HCWB N/A
- LUCY N/A
- EPS
- HCWB N/A
- LUCY N/A
- Revenue
- HCWB $3,495,990.00
- LUCY $1,561,506.00
- Revenue This Year
- HCWB $229.19
- LUCY $68.16
- Revenue Next Year
- HCWB N/A
- LUCY $636.84
- P/E Ratio
- HCWB N/A
- LUCY N/A
- Revenue Growth
- HCWB 22.27
- LUCY 158.62
- 52 Week Low
- HCWB $0.21
- LUCY $3.26
- 52 Week High
- HCWB $2.52
- LUCY $27.20
- Technical
- Relative Strength Index (RSI)
- HCWB 48.72
- LUCY 39.25
- Support Level
- HCWB $0.38
- LUCY $4.83
- Resistance Level
- HCWB $0.42
- LUCY $4.95
- Average True Range (ATR)
- HCWB 0.09
- LUCY 0.34
- MACD
- HCWB -0.00
- LUCY -0.03
- Stochastic Oscillator
- HCWB 4.48
- LUCY 27.27
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands free.